n South African Journal of Psychiatry - Product news




Extracted from text ... 80product news product product news product Lamictin for bipolar disorder The treatment of bipolar depression has been reported to be the greatest 'unmet need' and treatment challenge in the management of bipolar disorder. However, with the proven efficacy of Lamictin in delaying time to intervention for manic and depressive episodes, but with more robust efficacy against depression, Lamictin could cause a 'major treatment paradigm shift'. Registered for the prevention of mood episodes in patients over 18 years of age with bipolar disorder, predominantly by preventing depressive episodes, Lamictin has been classified as a class B mood stabiliser, in that it ..


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error